<?xml version="1.0" encoding="UTF-8"?>
<p id="par0045">Viral strains or cell lines expressing reporter proteins are also used to assess the efficacy of BSAAs in infected cells. For example, TZM-bl cells expressing firefly luciferase under control of HIV-1 LTR promoter allowed quantitation of BSAA action on HIV-1 infection (tat-protein expression by integrated HIV-1 provirus) using firefly luciferase assay (
 <xref rid="bib0410" ref-type="bibr">Sarzotti-Kelsoe et al., 2014</xref>, 
 <xref rid="bib0525" ref-type="bibr">Xing et al., 2016</xref>). RFP-expressing RVFV, nanoLuc-expressing CHIKV and RRV, as well as GFP-expressing FLUAV, HCV and HMPV also allowed identification of novel activities of several BSAAs (
 <xref rid="bib0020" ref-type="bibr">Andersen et al., 2019b</xref>, 
 <xref rid="bib0050" ref-type="bibr">Bosl et al., 2019</xref>, 
 <xref rid="bib0095" ref-type="bibr">de Graaf et al., 2007</xref>, 
 <xref rid="bib0160" ref-type="bibr">Habjan et al., 2008</xref>, 
 <xref rid="bib0190" ref-type="bibr">Ianevski et al., 2018</xref>, 
 <xref rid="bib0205" ref-type="bibr">Jupille et al., 2011</xref>, 
 <xref rid="bib0230" ref-type="bibr">Kittel et al., 2004</xref>, 
 <xref rid="bib0265" ref-type="bibr">Lee et al., 2017</xref>, 
 <xref rid="bib0490" ref-type="bibr">Utt et al., 2016</xref>). In addition, qPCR/RT-qPCR, RNA/DNA sequencing, RNA/DNA hybridization, immuno- and plaque assays as well as CRISPR-Cas9 systems could be used for detection of inhibitory effects of BSAAs (
 <xref rid="bib0040" ref-type="bibr">Boonham et al., 2014</xref>, 
 <xref rid="bib0140" ref-type="bibr">Fischer et al., 2017</xref>, 
 <xref rid="bib0240" ref-type="bibr">Konig et al., 2019</xref>, 
 <xref rid="bib0250" ref-type="bibr">Laamiri et al., 2018</xref>, 
 <xref rid="bib0255" ref-type="bibr">Landry, 1990</xref>, 
 <xref rid="bib0355" ref-type="bibr">Perez et al., 2013</xref>, 
 <xref rid="bib0415" ref-type="bibr">Sashital, 2018</xref>, 
 <xref rid="bib0575" ref-type="bibr">Zhou et al., 2018</xref>). Interestingly, CRISPR-Cas9, siRNA and shRNA approaches were used for identification of BSAA targets (
 <xref rid="bib0100" ref-type="bibr">Deans et al., 2016</xref>, 
 <xref rid="bib0375" ref-type="bibr">Puschnik et al., 2017</xref>).
</p>
